Ly-49E Activators represent a diverse group of chemical compounds that indirectly enhance the functional activity of Ly-49E, a protein predicted to play a role in carbohydrate binding and cell adhesion, and located in the plasma membrane. For instance, Phorbol 12-myristate 13-acetate (PMA) and Forskolin act by activating protein kinase C (PKC) and protein kinase A (PKA), respectively. PKC and PKA are critical in phosphorylating proteins involved in cell adhesion, a process where Ly-49E is predicted to function. Similarly, Sphingosine-1-phosphate (S1P) and Thapsigargin trigger pathways that are pivotal for cell adhesion; S1P through G protein-coupled receptor signaling and Thapsigargin by elevating intracellular calcium levels, thereby potentially augmenting Ly-49E's activity in these pathways. The kinase inhibitors Epigallocatechin gallate (EGCG), LY294002, Wortmannin, U0126, and SB203580 also play a role. EGCG, by modifying kinase activity, and LY294002 and Wortmannin, by inhibiting PI3K, shift cellular signaling dynamics towards those pathways where Ly-49E is active. Similarly, U0126 and SB203580, by inhibiting MEK1/2 and p38 MAPK, respectively, can enhance Ly-49E's role in cell adhesion.
Further, A23187 (Calcimycin) increases intracellular calcium levels, influencing calcium-dependent signaling processes crucial for cell adhesion, potentially boosting Ly-49E activity. Genistein, through tyrosine kinase inhibition, and Staurosporine, as a broad-spectrum protein kinase inhibitor, also contribute to the activation of Ly-49E. Genistein does so by reducing competitive signaling in cell adhesion pathways, while Staurosporine might selectively activate Ly-49E pathways by lifting inhibition on specific kinases involved in cell adhesion. Collectively, these compounds, through their targeted effects on various signaling pathways, enhance the functional activity of Ly-49E, particularly in processes related to cell adhesion and carbohydrate binding, demonstrating the complexity and interconnectivity of cellular signaling networks and their impact on specific protein functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which plays a key role in signal transduction pathways linked to the plasma membrane. Activation of PKC by PMA can lead to phosphorylation of downstream targets involved in cell adhesion, potentially enhancing the activity of Ly-49E, which is predicted to act within this process. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages with G protein-coupled receptors to activate signaling pathways involved in cell adhesion. This process can enhance the functional activity of Ly-49E, which is involved in cell adhesion processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates intracellular calcium levels by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). Elevated calcium can activate signaling pathways crucial for cell adhesion, potentially augmenting Ly-49E activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits certain kinases and modifies signaling pathways involved in cell adhesion. This modulation can lead to enhanced activity of Ly-49E in cell adhesion processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can shift signaling pathways toward those involved in cell adhesion, indirectly enhancing the functional activity of Ly-49E in these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which can indirectly promote pathways linked to cell adhesion, potentially enhancing Ly-49E activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, affecting MAPK/ERK pathway signaling. This inhibition can shift the balance toward pathways in which Ly-49E is active, particularly in cell adhesion. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and by modulating this pathway, it can influence cell adhesion processes in which Ly-49E is involved. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, thereby activating calcium-dependent signaling pathways crucial for cell adhesion, potentially enhancing Ly-49E activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can modulate cell adhesion pathways, potentially leading to enhanced Ly-49E function in these processes. | ||||||